Universal coronavirus vaccine
Ended Awarded Last action
- Contract number
- 75N93022F00002
- Awardee
-
Charles River Laboratories, Inc. UEI NAPSK1UAMAE5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $433,606
Award facts
- Contract value 100% obligated
- $433,606.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Wilmington, MA 01887, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | -$196,239 | |
| Change Order | $287,608 | |
| Other Administrative Action | $0 | |
| Original award | $342,237 |
About this award
This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Charles River Laboratories, Inc. for the development of a universal coronavirus vaccine. The contract has a ceiling value of $433,606.30 and a completion date of October 24, 2025. This award is not associated with a set-aside program. Charles River Laboratories is a global contract research organization that specializes in providing essential products and services to support pharmaceutical, biotechnology, and government research and development efforts, including animal research, preclinical and clinical laboratory services, and vaccine development. This contract supports NIAID's critical role in advancing medical countermeasures against emerging infectious diseases.
Quick answers
Who was awarded contract 75N93022F00002?
75N93022F00002 was awarded to Charles River Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 25, 2022.
How much is contract 75N93022F00002 worth?
The government has obligated $433,606 on 75N93022F00002.
Is contract 75N93022F00002 an order under another contract?
Yes. 75N93022F00002 is a delivery order under 75N93021D00018, an indefinite delivery contract.
Was contract 75N93022F00002 competed?
The extent of competition for 75N93022F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award